Background A rapid increase in incidence of the SARS-CoV-2 Omicron variant (sub-lineage
BA.1) occurred in France in December 2021, while the Delta variant was prevailing since …

Background Hepatocellular carcinoma (HCC) is one of the leading causes of cancer-related
deaths in Africa. In Africa, the major causes of HCC include chronic infection with hepatitis B …

In face of evidence of rapid waning of vaccine effectiveness against Omicron and its sub-lineages,
a second booster with mRNA vaccines was recommended for the most vulnerable in …

This commentary describes the need for a birth dose monovalent hepatitis B virus (HBV)
vaccine and an effective programme for the prevention of mother-to-child-transmission (MTCT) …

This cohort study aimed to evaluate the protection against symptomatic SARS-CoV-2 infection
conferred by the Pfizer-BioNTech Original/BA.4-5 bivalent vaccine compared to mRNA …

Background International sustainable development goals for the elimination of viral hepatitis
as a public health problem by 2030 highlight the need to optimize strategies for prevention, …

Higher academic institutions in the UK need to drive improvements in equity, diversity, and
inclusion (EDI) through sustainable practical interventions. A broad view of inclusivity is …

Background Given the widespread implementation of COVID-19 vaccination to mitigate the
pandemic from the end of 2020, it is important to retrospectively evaluate its impact, in …

Background Given projected shortages of critical care capacity in public hospitals during the
COVID-19 pandemic, the South African government embarked on an initiative to purchase …

Since the emergence of Omicron, reinfections with SARS-CoV-2 have been rising. We
estimated the risk of SARS-CoV-2 reinfection in the widely vaccinated French population, from …